PEONA, VITTORIA
 Distribuzione geografica
Continente #
NA - Nord America 471
EU - Europa 381
AS - Asia 256
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.111
Nazione #
US - Stati Uniti d'America 469
CN - Cina 246
IE - Irlanda 122
UA - Ucraina 78
FI - Finlandia 49
DE - Germania 47
SE - Svezia 36
GB - Regno Unito 17
BE - Belgio 12
IT - Italia 12
FR - Francia 7
IR - Iran 4
SG - Singapore 3
CA - Canada 2
EG - Egitto 2
EU - Europa 1
JP - Giappone 1
LV - Lettonia 1
TR - Turchia 1
TW - Taiwan 1
Totale 1.111
Città #
Dublin 122
Chandler 120
Jacksonville 94
Nanjing 76
Ann Arbor 56
Beijing 45
Nanchang 28
Ashburn 23
Lawrence 19
Princeton 19
Wilmington 18
Hebei 17
Shenyang 16
Shanghai 15
Helsinki 13
Brussels 12
Jiaxing 11
Tianjin 11
Woodbridge 11
Boardman 10
Hangzhou 9
Medford 7
Verona 6
Changsha 5
Kunming 5
Milan 5
Norwalk 5
Falls Church 4
Piscataway 4
Seattle 4
Jinan 3
Cairo 2
Leawood 2
Nantes 2
Singapore 2
Toronto 2
Asaka 1
Auburn Hills 1
Berlin 1
Des Moines 1
Fairfield 1
Framingham 1
Henderson 1
Kashan 1
Lanzhou 1
Los Angeles 1
Nottingham 1
Redwood City 1
Sacramento 1
Shijiazhuang 1
Tainan City 1
Taizhou 1
Tappahannock 1
Washington 1
Wiesbaden 1
Zanjan 1
Totale 823
Nome #
Familial elevation of serum angiotensin converting enzyme activity. 88
Onset of asthma in hairdresser 77
Studies of MR 889, a new synthetic proteinase inhibitor. 72
Nebulized tobramycin in patients with chronic respiratory infections during clinical evolution of Wegener's granulomatosis. 71
Increased serum inflammatory markers as predictors of airway obstruction. 69
Some properties of the alkaline proteinase from Aspergillus melleus. 67
Serum eosinophilic cationic protein: is there a role in respiratory disorders? 63
Diagnosis of enigmatic chronic cough Neurovascular compression in a case of chronic cough progressively leading to compromised quality of life 62
Ambroxol and pulmonary toxicity induced by antineoplastic drugs. 60
HLA markers in sarcoidosis. 60
On the activity of MR 889, a new synthetic proteinase inhibitor. 58
Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy. 57
Protease-antiprotease imbalance: local evaluation with bronchoalveolar lavage. 55
Mechanisms of lung injury in cystic fibrosis. 54
The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease. 53
Increased serum inflammatory markers as predictors of airway obstruction. 52
Alpha 1-antitrypsin variants produced by recombinant DNA: differences in elastase inhibitory activity and resistance to oxidant agents. 46
Serum type I and type III procollagen peptide levels in sarcoidosis. 37
Increased serum inflammatory markers as predictors of airway obstruction 17
Totale 1.118
Categoria #
all - tutte 3.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020302 76 101 0 19 1 16 7 16 0 20 46 0
2020/2021176 20 16 6 19 1 21 2 27 6 26 24 8
2021/202287 2 3 2 3 5 2 3 7 4 2 17 37
2022/2023327 29 28 16 27 43 24 0 14 136 3 6 1
2023/202494 11 25 2 7 11 9 2 12 3 2 7 3
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 1.118